Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Prevention of PGE2-induced bladder overactivity by TRPM8 blocker DFL-23448

April 17, 2014

Multiple studies examine treatment of HCV infection with veruprevir/ritonavir/ombitasvir combination

April 17, 2014

Sym-013 augments response to lung and head and neck cancer tumors

April 17, 2014

Researchers present a novel method to predict the risk of rejection after heart transplant

April 17, 2014

Neuregulin-1 expression correlates with sensitivity to GDC-0032 PI3K inhibitor

April 17, 2014

Interstitial deletion of 8p23.1 indicates a new causative gene for heterotaxy

April 17, 2014

Sigma-Tau describes novel HSP 90 inhibitor

April 17, 2014

Phase I results for MRX-34, a first-in-class liposome formulated miR-34 mimic

April 17, 2014

Novel putative antisense mitochondrial RNA-based therapy for renal cell carcinoma

April 16, 2014

TT-genotype of IL-23R has protective effect in lung transplant recipients

April 16, 2014

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...